lip1/ApoB siRNA (Pfizer)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug Namelip1/ApoB siRNA (Pfizer)

Drug Alias Namesi147

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionApolipoprotein B-100 inhibitors

TargetsApolipoprotein B-100

Therapy Area/IndicationsCarcinoma, Hepatocellular

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsCarcinoma, Hepatocellular

ATC CodeN/A